Last reviewed · How we verify
NCT06167564
Allergy Diagnostic Test Based on Microchip Technology
NA trial testing Routine allergy tests in Allergy in 400 participants. Status unknown.
31 December 2024
Quick facts
| Lead sponsor | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 400 |
| Start date | 1 January 2024 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Belarus |
Drugs / interventions tested
- Routine allergy tests
- Newly developed microarray-based diagnostic test system
Conditions studied
- Allergy — all drugs for Allergy →
- Allergy;Food — all drugs for Allergy;Food →
- Allergy Pollen — all drugs for Allergy Pollen →
- Allergy Drug — all drugs for Allergy Drug →
Sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Who can join
Adults 18 to 80, any sex, with Allergy or Allergy;Food. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to develop a microarray-based diagnostic test system for the determination of allergen specific IgE in human blood serum.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06167564
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Allergy
Currently open trials in the same condition.
- NCT05997784 — Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing · active not recruiting
- NCT06390878 — Nationwide Research on the Rewilding of Kindergarten Yards · NA · recruiting
- NCT06248957 — SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION · recruiting
- NCT05449756 — A Follow-up Study With Children Who Participated in the TEMPO Study in Their First Year of Life · recruiting
- NCT06192914 — EPAP, Interviewstudy · recruiting
Other Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus trials
Trials by the same sponsor.
- NCT05654766 — Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies · unknown
- NCT05520125 — Treatment of Patients With Bone Tissue Defects Using Mesenchymal Stem Cells Enriched by Extracellular Vesicles · Phase 1, PHASE2 · unknown
- NCT05520112 — Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells · Phase 1, PHASE2 · unknown
- NCT05214014 — Treatment of Systemic Sclerosis With Autologous Regulatory Т-cells · Phase 1, PHASE2 · unknown
- NCT05187104 — Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells · Phase 1, PHASE2 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06167564 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
- Last refreshed: 12 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06167564.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing